Anti-Tumor Effect and Mechanism of Bletilla Rhizoma Based on Network Pharmacology

Xiusheng Tang,Rongze Fang,Ling Li,Jun Luo,Ling Li and Jun Luo
DOI: https://doi.org/10.1088/1757-899X/914/1/012009
2020-09-21
IOP Conference Series: Materials Science and Engineering
Abstract:Bletilla Rhizoma is a traditional Chinese medicine used for hemostasis. Modern research shows that Bletilla Rhizoma has anti-tumor effect, but its mechanism is not clear. We obtained the active chemical components and targets of Bletilla Rhizoma through the systematic pharmacology database of Traditional Chinese Medicine (TCMSP), and established the data set of the intersectionof active components and disease targets. The protein-protein interaction network (PPI) was used to analyze the protein interaction network of Bletilla Rhizoma active components target and tumortarget. The biological information annotation database (DAVID) was used to perform gene ontology (GO) function enrichment analysis and based on Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis to predict related mechanisms of anti-tumor effects of Bletilla Rhizoma. 15 active components were obtained from TCMSP, and 40 potential targets were screened out through the evaluation of the network topology. The DAVID database was used to perform gene GO functional enrichment analysis and KEGG pathway enrichment analysis on 40 potential target targets to screen for participation. The first 20 biological processes and signaling pathways involved in the anti-tumor effect of Bletilla Rhizoma were screened out. Through network pharmacology, we have drawn the conclusion that the anti-tumor effect of Bletilla Rhizoma is mainly regulated by pathways such as insulin resistance, legionelosis and proteoglycans in cancer, among which the proteoglycans in cancer pathwayhas a strong correlation with cancer, and its anti-cancer pathway is closely related to TNF, a key target.
What problem does this paper attempt to address?